Exyte Acquires TTP Group

November 5, 2024

Exyte has completed the acquisition of TTP Group, a European engineering firm operating under the Pharmaplan and Triplan brands that serves biotech, pharmaceutical and chemical clients. The deal, which closed after receiving all required regulatory approvals, strengthens Exyte’s biopharma and life sciences capabilities and expands its presence across Europe.

Buyers
Exyte
Targets
TTP Group
Location
Germany
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.